EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Crocin promotes ferroptosis in gastric cancer via the Nrf2/GGTLC2 pathway

Nan Yan, Gaofu Li, Linglin Zhao, Qijing Guo, Jie Yang, Jianhong Liu, Wei Zhou, Yue Gao, Yushuang Luo

Frontiers in Pharmacology · 21.03.2025 · 16

DOI: 10.3389/fphar.2025.1527481 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 21.03.2025. Verfasst von Nan Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for High Altitude Medicine, Key Laboratory of High Altitude Medicine (Ministry of Education), Key Laboratory of High Altitude Medicin…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Gastric cancer (GC) is characterized by high incidence and poor survival rates. Crocin, a natural carotenoid from saffron, exhibits antioxidant, anti-inflammatory, and anti-tumor properties. Ferroptosis, an iron-dependent cell death driven by lipid peroxidation, plays a critical role in cancer progression and is a potential therapeutic target. This study investigates whether crocin inhibits GC cell proliferation by inducing ferroptosis and explores its underlying mechanisms.

Methods

This study employed in vivo and in vitro models to assess crocin’s effects on GC cell proliferation, apoptosis, migration, invasion, and ferroptosis. Pathway enrichment analysis was performed on differentially expressed genes post-crocin treatment. Lentiviral vectors were used to knockdown and overexpress GGTLC2, exploring its role in GC progression and crocin’s therapeutic effects. The UCSC and JASPAR databases predicted Nrf2 binding sites in the GGTLC2 promoter. Molecular docking evaluated crocin’s affinity for Nrf2 and GGTLC2. Immunofluorescence and nuclear-cytoplasmic fractionation assays analyzed Nrf2 expression and localization. ChIP-qPCR determined Nrf2’s regulatory role on GGTLC2 and crocin’s modulatory effects.

Results

The results demonstrated that crocin significantly inhibited the proliferation, migration, and invasion of GC cells while promoting apoptosis. Differentially expressed genes following crocin treatment were predominantly enriched in pathways associated with oxidative stress and ferroptosis. Crocin downregulated the oncogene GGTLC2, thereby suppressing GC cell proliferation, invasion, and migration, while simultaneously promoting apoptosis and ferroptosis. Molecular docking analysis revealed a stable binding affinity between crocin and GGTLC2, suggesting that crocin may directly target GGTLC2 to modulate its expression. Additionally, crocin facilitated the translocation of Nrf2 from the nucleus to the cytoplasm. ChIP-qPCR results confirmed that Nrf2 directly binds to the GGTLC2 promoter region to regulate its expression, and crocin attenuated this binding interaction.

Discussion

In conclusion, our findings suggest that crocin, as a promising natural compound for GC therapy, may inhibit ferroptosis in GC cells through the Nrf2/GGTLC2 signaling pathway, thereby suppressing tumor initiation and progression. This study provides novel insights into the molecular mechanisms underlying the anti-tumor effects of crocin and highlights its potential as a therapeutic agent for GC.

Schlagwörter

Stichwörter der Autor:innen

GGTLC2Nrf2crocinferroptosisgastric cancer

Autor:innen und Institutionen

  • Research Center for High Altitude Medicine, Key Laboratory of High Altitude Medicine (Ministry of Education), Key Laboratory of High Altitude Medicine in Qinghai Province, Qinghai Province Plateau Medicine Applied and B…
  • Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, China.
  • Department of oncology, Air force medical center. PLA, Beijing, China.
  • Affiliated Hospital of Qinghai University, Xining, Qinghai, China.
  • College of Humanities and Technology, QingHai Open University, Xining, China.
  • State Key Laboratory of Kidney Diseases, Chinese PLA General Hospital, Beijing, China.

Zitieren

APA

Yan, N., Li, G., Zhao, L., Guo, Q., Yang, J., Liu, J., Zhou, W., Gao, Y., & Luo, Y. (2025). Crocin promotes ferroptosis in gastric cancer via the Nrf2/GGTLC2 pathway. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1527481

Vancouver

Yan N, Li G, Zhao L, Guo Q, Yang J, Liu J, et al. Crocin promotes ferroptosis in gastric cancer via the Nrf2/GGTLC2 pathway. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1527481

BibTeX
@article{Yan2025,
  author = {Yan, Nan and Li, Gaofu and Zhao, Linglin and Guo, Qijing and Yang, Jie and Liu, Jianhong and Zhou, Wei and Gao, Yue and Luo, Yushuang},
  title = {Crocin promotes ferroptosis in gastric cancer via the Nrf2/GGTLC2 pathway},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1527481}
}
Kostenlos starten →